Gastrointestinal Delivery of an mRNA Vaccine Using Immunostimulatory Polymeric Nanoparticles

mRNA vaccines can be translated into protein antigens, in vivo, to effectively induce humoral and cellular immunity against these proteins. While current mRNA vaccines have generated potent immune responses, the need for ultracold storage conditions (− 80 °C) and healthcare professionals to administer the vaccine through the parenteral route has somewhat limited their distribution in rural areas and developing countries. Overcoming these challenges stands to transform future deployment of mRNA vaccines. In this study, we developed an mRNA vaccine that can trigger a systemic immune response through administration via the gastrointestinal (GI) tract and is stable at 4 °C. A library of cationic branched poly(β-amino ester) (PBAE) polymers was synthesized and characterized, from which a polymer with high intracellular mRNA delivery efficiency and immune stimulation capacity was down-selected. mRNA vaccines made with the lead polymer-elicited cellular and humoral immunity in mice. Furthermore, lyophilization conditions of the formulation were optimized to enable storage under refrigeration. Our results suggest that PBAE nanoparticles are potent mRNA delivery platforms that can elicit B cell and T cell activation, including antigen-specific cellular and humoral responses. This system can serve as an easily administrable, potent oral mRNA vaccine.

[1]  Shriya S. Srinivasan,et al.  RoboCap: Robotic mucus-clearing capsule for enhanced drug delivery in the gastrointestinal tract , 2022, Sci. Robotics.

[2]  R. Siegel,et al.  An Artificial Gut/Absorption Simulator: Description, Modeling, and Validation Using Caffeine , 2022, The AAPS Journal.

[3]  M. Ji,et al.  Laparotomy-Induced Peripheral Inflammation Activates NR2B Receptors on the Brain Mast Cells and Results in Neuroinflammation in a Vagus Nerve-Dependent Manner , 2022, Frontiers in Cellular Neuroscience.

[4]  Ameya R. Kirtane,et al.  Oral mRNA delivery using capsule-mediated gastrointestinal tissue injections , 2022, Matter.

[5]  Aaron M. Rosenfeld,et al.  Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses , 2021, Immunity.

[6]  R. Haque,et al.  Oral rotavirus vaccine shedding as a marker of mucosal immunity , 2021, Scientific Reports.

[7]  G. Domańska,et al.  Increased mortality and altered local immune response in secondary peritonitis after previous visceral operations in mice , 2021, Scientific Reports.

[8]  A. Anselmo,et al.  Modulating Oral Delivery and Gastrointestinal Kinetics of Recombinant Proteins via Engineered Fungi , 2021, The AAPS Journal.

[9]  I. Mellman,et al.  IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines , 2022, Nature Immunology.

[10]  K. Nam,et al.  Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver , 2021, Science Advances.

[11]  W. Jiskoot,et al.  Addressing the Cold Reality of mRNA Vaccine Stability , 2020, Journal of Pharmaceutical Sciences.

[12]  C. Duvall,et al.  Structural Optimization of Polymeric Carriers to Enhance the Immunostimulatory Activity of Molecularly Defined RIG-I Agonists , 2020, ACS central science.

[13]  Ameya R. Kirtane,et al.  Gastrointestinal synthetic epithelial linings , 2020, Science Translational Medicine.

[14]  R. Langer,et al.  Advances in oligonucleotide drug delivery , 2020, Nature Reviews Drug Discovery.

[15]  J. Mascola,et al.  SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness , 2020, Nature.

[16]  Xia Zhong,et al.  A Thermostable mRNA Vaccine against COVID-19 , 2020, Cell.

[17]  J. Mascola,et al.  An mRNA Vaccine against SARS-CoV-2 — Preliminary Report , 2020, The New England journal of medicine.

[18]  D. Ferguson,et al.  TLR7/8 Agonist Loaded Nanoparticles Augment NK Cell-mediated Antibody-based Cancer Immunotherapy. , 2020, Molecular pharmaceutics.

[19]  Juan F Burgueño,et al.  Epithelial Toll-like receptors and their role in gut homeostasis and disease , 2020, Nature Reviews Gastroenterology & Hepatology.

[20]  S. Gurunathan,et al.  The promise of mRNA vaccines: a biotech and industrial perspective , 2020, npj Vaccines.

[21]  A. Depicker,et al.  Evaluating single-domain antibodies as carriers for targeted vaccine delivery to the small intestinal epithelium. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[22]  Na Yoon Kim,et al.  Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition , 2019, Science Translational Medicine.

[23]  R. Weiss,et al.  Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  Robert Langer,et al.  A luminal unfolding microneedle injector for oral delivery of macromolecules , 2019, Nature Medicine.

[25]  M. Lu,et al.  Engineering a Nanoscale Al‐MOF‐Armored Antigen Carried by a “Trojan Horse”‐Like Platform for Oral Vaccination to Induce Potent and Long‐Lasting Immunity , 2019, Advanced Functional Materials.

[26]  D. Esterházy,et al.  Compartmentalized gut lymph node drainage dictates adaptive immune responses , 2019, Nature.

[27]  Robert Langer,et al.  An ingestible self-orienting system for oral delivery of macromolecules , 2019, Science.

[28]  Ronnie H. Fang,et al.  Biomimetic Micromotor Enables Active Delivery of Antigens for Oral Vaccination. , 2019, Nano letters.

[29]  N. Grassly,et al.  Interventions to improve oral vaccine performance: a systematic review and meta-analysis , 2019, The Lancet. Infectious diseases.

[30]  J. Kolls,et al.  Faculty Opinions recommendation of B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4+ T Cells upon Immunization with a Virus-Derived Nanoparticle Antigen. , 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[31]  Fuping Zhang,et al.  B Cells Are the Dominant Antigen‐Presenting Cells that Activate Naive CD4+ T Cells upon Immunization with a Virus‐Derived Nanoparticle Antigen , 2018, Immunity.

[32]  D. Ferguson,et al.  Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy. , 2018, Biomaterials.

[33]  D. Weissman,et al.  mRNA vaccines — a new era in vaccinology , 2018, Nature Reviews Drug Discovery.

[34]  N. Grassly,et al.  Causes of impaired oral vaccine efficacy in developing countries , 2017, Future microbiology.

[35]  C. Jewell,et al.  A poly(beta-amino ester) activates macrophages independent of NF-κB signaling. , 2017, Acta biomaterialia.

[36]  Kimberly J. Hassett,et al.  Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[37]  James I. Andorko,et al.  Impact of molecular weight on the intrinsic immunogenic activity of poly(beta amino esters). , 2017, Journal of biomedical materials research. Part A.

[38]  D. Accoto,et al.  A Swallowable Smart Pill for Local Drug Delivery , 2016, Journal of Microelectromechanical Systems.

[39]  M. Coimbra,et al.  Structure-function relationships of immunostimulatory polysaccharides: A review. , 2015, Carbohydrate polymers.

[40]  N. Fierer,et al.  The Evolution of Stomach Acidity and Its Relevance to the Human Microbiome , 2015, PloS one.

[41]  L. McAllister,et al.  Needle-free jet injection for administration of influenza vaccine: a randomised non-inferiority trial , 2014, The Lancet.

[42]  C. Herzog.  Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature , 2014, Expert review of vaccines.

[43]  G. Vanham,et al.  Challenges and advances towards the rational design of mRNA vaccines. , 2013, Trends in molecular medicine.

[44]  C. Ballantyne,et al.  CD11a Regulates Effector CD8 T Cell Differentiation and Central Memory Development in Response to Infection with Listeria monocytogenes , 2013, Infection and Immunity.

[45]  Zhaolin Hua,et al.  TLR signaling in B-cell development and activation , 2012, Cellular and Molecular Immunology.

[46]  Nathaniel S Wang,et al.  Molecular programming of B cell memory , 2011, Nature Reviews Immunology.

[47]  Y. Schneider,et al.  Targeting nanoparticles to M cells with non-peptidic ligands for oral vaccination. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[48]  N. Van Rooijen,et al.  Dendritic Cell-Induced Memory T Cell Activation in Nonlymphoid Tissues , 2008, Science.

[49]  Gideon Kersten,et al.  Needle-free vaccine delivery , 2007, Expert opinion on drug delivery.

[50]  D. Weissman,et al.  mRNA Is an Endogenous Ligand for Toll-like Receptor 3* , 2004, Journal of Biological Chemistry.

[51]  F. Sallusto,et al.  Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells , 2000, Nature Immunology.

[52]  Lei Zhang,et al.  Controlled and targeted release of antigens by intelligent shell for improving applicability of oral vaccines. , 2016, Biomaterials.

[53]  R. Mumper,et al.  In Vitro and In Vivo Evaluation of a Water-in-Oil Microemulsion System for Enhanced Peptide Intestinal Delivery , 2012, The AAPS Journal.

[54]  A. Stammati,et al.  The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics , 2005, Cell Biology and Toxicology.

[55]  Myron M. Levine,et al.  Can needle-free administration of vaccines become the norm in global immunization? , 2003, Nature Medicine.

[56]  I. Wilding,et al.  Enteric coated HPMC capsules designed to achieve intestinal targeting. , 2002, International journal of pharmaceutics.